In-Home Genetic Tests Represent Risk
By Jesse Reynolds,
Newsday
| 10. 22. 2007
Residents of Long Island and elsewhere in the Northeast will soon see television ads recommending they "Be ready against cancer." One might assume these to be public service announcements calling for more exercise or diets rich in antioxidants. Instead, the ads will promote a test for genes related to breast cancer.
Although this will be the first major direct-to-consumer campaign promoting genetic testing, the manufacturer of the test will not be mentioned. Instead, small text at the bottom of the screens will let viewers know the ad is a "service" of Myriad Genetics, which holds patents on the tested genes.
Myriad's test is likely to be the tip of the iceberg, and what it suggests for the future is quite alarming. We'll soon see more advertising campaigns that, like those of drugs, prey on our insecurities and fears. And unlike Myriad's test, which must be ordered through your doctor, an increasing number of these will be available over the counter and performed in the privacy - and isolation - of your own home.
This trend highlights three troubling aspects of...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Katrina Miller, The New York TImes | 02.05.2026
Joseph Yracheta: The Native Biodata Consortium is the first nonprofit data and sample repository within the geographic bounds and legal jurisdiction of an American Indian nation, on the Cheyenne River Sioux Reservation in Eagle Butte, S.D.
NativeBio participated in a ...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...